Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
- PMID: 10500189
- PMCID: PMC18046
- DOI: 10.1073/pnas.96.20.11404
Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
Abstract
Pathological degeneration of neurons in Huntington's disease and associated neurodegenerative disorders is directly correlated with the expansion of CAG repeats encoding polyglutamines of extended length. The physical properties of extended polyglutamines and the intracellular consequences of expression of polyglutamine expansion have been the object of intensive investigation. We have extended the range of lengths of polyglutamine produced by recombinant DNA methodology by constructing a library of CAG/CAA repeats coding for a range of 25-300 glutamine residues. We have investigated the subcellular localization, interaction with other polyglutamine-containing polypeptides, and the physical properties of aggregated forms of polyglutamine in the cell. Extended polyQ aggregated in the cytoplasm and was only transported to the nucleus when a strong nuclear localization signal was present. Polyglutamine below pathological lengths could be captured in aggregates and transported to ectopic cell locations. The CREB-binding protein (CBP), containing a homopolymeric stretch of 19 glutamines, was likewise found to coaggregate in a polyglutamine-dependent manner, suggesting that pathology in polyglutamine disease may result from cellular depletion of normal proteins containing polyglutamine. We have observed a striking detergent resistance in aggregates produced from polyglutamine of pathological length. This observation has led to the development of a fluorescence-based assay exploiting the detergent resistance of polyglutamine aggregates that should facilitate high-throughput screening for agents that suppress polyglutamine aggregation in cells.
Figures




Similar articles
-
Evidence for a recruitment and sequestration mechanism in Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1029-34. doi: 10.1098/rstb.1999.0455. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434302 Free PMC article.
-
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.Science. 2001 Mar 23;291(5512):2423-8. doi: 10.1126/science.1056784. Science. 2001. PMID: 11264541
-
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5. Somat Cell Mol Genet. 1998. PMID: 10410676
-
Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1013-9. doi: 10.1098/rstb.1999.0453. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434300 Free PMC article. Review.
-
Proteomics of polyglutamine aggregates.Methods Enzymol. 2006;412:63-76. doi: 10.1016/S0076-6879(06)12005-4. Methods Enzymol. 2006. PMID: 17046652 Review.
Cited by
-
The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology.Curr Trends Neurol. 2011 Jan 1;5:65-78. Curr Trends Neurol. 2011. PMID: 22180703 Free PMC article.
-
Developmental expression of DAX1 in the European sea bass, Dicentrarchus labrax: lack of evidence for sexual dimorphism during sex differentiation.Reprod Biol Endocrinol. 2007 May 30;5:19. doi: 10.1186/1477-7827-5-19. Reprod Biol Endocrinol. 2007. PMID: 17537257 Free PMC article.
-
CRE-mediated transcription is increased in Huntington's disease transgenic mice.J Neurosci. 2004 Jan 28;24(4):791-6. doi: 10.1523/JNEUROSCI.3493-03.2004. J Neurosci. 2004. PMID: 14749423 Free PMC article.
-
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.J Neurosci. 2004 Sep 1;24(35):7727-39. doi: 10.1523/JNEUROSCI.1197-04.2004. J Neurosci. 2004. PMID: 15342740 Free PMC article.
-
Polyglutamine disease and neuronal cell death.Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12957-8. doi: 10.1073/pnas.210395797. Proc Natl Acad Sci U S A. 2000. PMID: 11058149 Free PMC article. No abstract available.
References
-
- The Huntington’s Disease Collaborative Research Group. Cell. 1993;72:971–983. - PubMed
-
- Reddy P S, Housman D E. Curr Opin Cell Biol. 1997;9:364–372. - PubMed
-
- Ross C A. Neuron. 1997;19:1147–1150. - PubMed
-
- White J K, Auerbach W, Duyao M P, Vonsattel J P, Gusella J F, Joyner A L, MacDonald M E. Nat Genet. 1997;17:404–410. - PubMed
-
- Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies S W, Bates G P. Cell. 1996;87:493–506. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases